Kim M. G. van der Wurff‐Jacobs

Thymic Stromal Lymphopoietin, a Novel Proinflammatory Mediator in Rheumatoid Arthritis That Potently Activates CD1c+ Myeloid Dendritic Cells to Attract and Stimulate T Cells

Frederique M. Moret, Cornelis E. Hack, Kim M. G. van der Wurff‐Jacobs et al. · Arthritis & Rheumatology · 2014 · 57 citations

Medicine, Immunology, Internal Medicine +17

Tumor Drug Distribution after Local Drug Delivery by Hyperthermia, In Vivo

Helena C. Besse, A.D. Barten-van Rijbroek, Kim M. G. van der Wurff‐Jacobs et al. · Cancers · 2019 · 40 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Numbers of CD25+Foxp3+ T cells that lack the IL-7 receptor are increased intra-articularly and have impaired suppressive function in RA patients

Joël A. G. van Roon, Sarita A. Y. Hartgring, Kim M. G. van der Wurff‐Jacobs et al. · Lara D. Veeken · 2010 · 35 citations

Life Sciences, Immunology, Autoimmunity +14

MicroRNA-130a Contributes to Type-2 Classical DC-activation in Sjögren's Syndrome by Targeting Mitogen- and Stress-Activated Protein Kinase-1

Ana P. Lopes, Joël A. G. van Roon, Sofie L. M. Blokland et al. · Frontiers in Immunology · 2019 · 22 citations · Full text

Life Sciences, Immunology, Pathology +17

Clinical efficacy of leflunomide in primary Sjögren's syndrome is associated with regulation of T-cell activity and upregulation of IL-7 receptor α expression

A. Bikker, Jan-Maarten van Woerkom, Aike A. Kruize et al. · Annals of the Rheumatic Diseases · 2012 · 21 citations

Life Sciences, Immunology, Pharmacology +17